Introduction to the PROSPER Trial (webinar)

About the Webinar:

Join CurePSP and Dr. Guenter Hoglinger to learn about the PROSPER Trial, a phase 2 clinical trial for people living with PSP. Dr. Hoglinger will present information about the investigational drug and the trial. He will also answer questions from the community and discuss important patient considerations.

About the Speaker:

Günter Höglinger is the Director of the Department of Neurology at the Ludwig-Maximilians-Universität (LMU). He is also the Senior Scientist at the German Center for Neurodegenerative Diseases (DZNE) and Principal Investigator at the Cluster of Excellence for Systems Neurology (SyNergy), Munich, Germany. His previous experiences include Chair of Translational Neurodegeneration at the Technical University of Munich (TUM) and Director of the Department of Neurology at Hannover Medical School. He is a member of the Scientific Advisory Board (SAB) of the CurePSP Foundation. His scientific work focusses tauopathies and synucleinopathies with a translational perspective, ranging from genetics, modelling, biomarker discovery to therapeutic trials.

Register

Donate